Literature DB >> 8052078

Factors affecting survival of patients with tumors of the anterior skull base.

T V McCaffrey1, K D Olsen, J M Yohanan, J E Lewis, M J Ebersold, D G Piepgras.   

Abstract

Fifty-four patients with primary neoplasms of the anterior skull base were treated by craniofacial resection with curative intent. The most common tumor was esthesioneuroblastoma (24), followed by squamous cell carcinoma (10). The overall 2-year and 5-year survivals were 75% and 49%, respectively. High-grade tumors, grades 3 and 4, had a poorer prognosis. Tumor size, dural involvement, sphenoid sinus involvement, age, and sex had no significant influence on survival when examined by multivariate survival analysis. Sixteen complications were noted in the postoperative period. Cerebrospinal fluid leakage occurred in 2 patients and loss of frontal bone occurred in 4. There were no operative or perioperative deaths. Craniofacial resection permits surgical resection of the majority of anterior skull base tumors with acceptable morbidity.

Entities:  

Mesh:

Year:  1994        PMID: 8052078     DOI: 10.1288/00005537-199408000-00006

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

1.  Olfactory neuroblastomas: survival rate and prognostic factor.

Authors:  Sung-Kyun Hwang; Sun-Ha Paek; Dong Gyu Kim; Yoon-Kyung Jeon; Je G Chi; Hee-Won Jung
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

2.  Combined craniofacial resection of anterior skull base tumors: long-term results and experience of single institution.

Authors:  Bashar Abuzayed; Bulent Canbaz; Galip Zihni Sanus; Seckin Aydin; Harun Cansiz
Journal:  Neurosurg Rev       Date:  2010-09-29       Impact factor: 3.042

3.  Midline anterior craniofacial approach for malignancy: results of en bloc versus piecemeal resections.

Authors:  B J Wellman; V C Traynelis; T M McCulloch; G F Funk; A H Menezes; H T Hoffman
Journal:  Skull Base Surg       Date:  1999

4.  Functional outcomes of the retromaxillary-infratemporal fossa dissection for advanced head and neck/skull base lesions.

Authors:  T Y Shibuya; T D Doerr; R H Mathog; D L Burgio; R J Meleca; G H Yoo; M Guthikonda
Journal:  Skull Base Surg       Date:  2000

5.  Sinonasal undifferentiated carcinoma: current trends in treatment.

Authors:  K T Pitman; P D Costantino; L F Lassen
Journal:  Skull Base Surg       Date:  1995

6.  The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation.

Authors:  L Madison Michael; Jeffrey M Sorenson; Sandeep Samant; Jon H Robertson
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

7.  [Navigated "targeted surgery" for skull base malignomas: additional space for surgical manipulation by neoadjuvant tumor downsizing].

Authors:  J Schipper; A Berlis; T Klenzner; A Schramm; N-C Gellrich; S Rosahl; W Maier
Journal:  HNO       Date:  2007-06       Impact factor: 1.284

Review 8.  Craniofacial resection for malignant tumours involving the anterior skull base.

Authors:  Giulio Cantù; Stefano Riccio; Gabriella Bimbi; Massimo Squadrelli; Sarah Colombo; Alvaro Compan; Marco Rossi; Madia Pompilio; Carlo L Solero
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-15       Impact factor: 2.503

9.  Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival.

Authors:  Jamie J Van Gompel; Caterina Giannini; Kerry D Olsen; Eric Moore; Manolo Piccirilli; Robert L Foote; Jan C Buckner; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2012-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.